Ramesh Hariharan, MD, FHRS
Basic profileThe University of Texas Health Science Center
Ramesh Hariharan is a Cardiology physician affiliated with The University of Texas Health Science Center. OpenAlex indexes 92 publications with 2,356 citations (h-index 21); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6400 Fannin St Ste 2550
Houston, TX 770301538
Telephone
713-486-1625Provider last certified this registry record 22 Sept 2022.
Clinical trials
- Precision Ablation For Pulmonary Vein Isolation: Targeting Pulmonary Vein Myocardial Sleeves (PVMS) With Omnipolar Mapping Technology
Sponsor: The University of Texas Health Science Center, Houston
- Structure Function Correlation in Primary Open Angle Glaucoma
Sponsor: Vasan Eye Care Hospital
- Anastomotic Techniques in Pancreaticoduodenectomy
Sponsor: Lakeshore Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202540 payments
- Medtronic, Inc.Program year202527 payments
- Biosense Webster, Inc.Program year202516 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.7%Beta blocker33.2%Metoprolol Succinate51%Sotalol33%Carvedilol16%Part D≥50 patientsAntiarrhythmic29.5%Flecainide Acetate46%Dofetilide27%Amiodarone Hcl27%Part D≥41 patients+ 5 more classes in this area
Blood & clotting
17.6%Factor Xa inhibitor17.6%Eliquis86%Xarelto14%Part D<11 patientsMetabolism & gastrointestinal
1.9%Proton pump inhibitor1.9%Pantoprazole Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- PULSED FIELD ABLATION OF ATYPICAL ATRIAL FLUTTER IN A PATIENT WITH CONGENITAL HEART DISEASE AND FONTAN PHYSIOLOGY
Journal of the American College of Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
John Reveille, MD
The University of Texas Health Science Center
Hazim Safi, MD
The University of Texas Health Science Center
Jimmy Espinoza, MD
The University of Texas Health Science Center
Adelaide Hebert, MD
The University of Texas Health Science Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”